Lexapro®
Escitalopram
Version 2025-04 · Last reviewed April 1, 2025 · Methodology
List Price
$120
With Insurance
$10-30
FDA Black Box Warning
INCREASED SUICIDAL THOUGHTS IN UNDER 25
Monitor closely in first months.
Strict Contraindications
How It Works
Escitalopram is the most selective SSRI available. It blocks serotonin reuptake via two binding sites on the SERT transporter — the primary active site plus a unique allosteric site — making it more effective at keeping the transporter blocked than other SSRIs at equivalent doses.
Why the side effects happen
Because escitalopram is so selective for SERT, it has minimal off-target receptor effects. Side effects are almost entirely serotonin-mediated: initial nausea (GI serotonin receptors), sexual dysfunction (dopamine suppression via serotonin), and sleep changes. This selectivity is why escitalopram causes less sedation, less weight gain, and fewer anticholinergic effects than older antidepressants.
When Will I Feel It?
One of the faster-acting SSRIs. Sleep and energy improvements often begin at 1–2 weeks. Depression and anxiety typically resolve at 4–6 weeks.
Mild nausea and possible jitteriness as serotonin floods the system. Usually manageable with food.
Sleep quality, energy, and concentration often improve before mood. Many patients notice they're "functioning better" before they feel emotionally better.
Core depressive symptoms improve in most responders. Consider this the minimum adequate trial.
Full response for anxiety disorders (GAD, social anxiety, panic). Response may continue building.
Adherence Note
Escitalopram's half-life (~27–32 hours) is long enough that missing a single dose is unlikely to cause discontinuation symptoms — unlike paroxetine. However, abrupt stopping after long-term use can still cause dizziness and irritability.
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Common Side Effects
While taking this medication, you may experience the following common side effects. We've included tips on how to manage them.
Nausea
15%Take with food; improves significantly after 1-2 weeks
Sexual dysfunction
14-20%Talk to your doctor; options include dose adjustment or adding another medication
Insomnia
14%Take in the morning; sleep hygiene practices help
Diarrhea
12%Usually improves with time; take with food
Dry mouth
9%Sip water frequently; sugar-free gum helps
Headache
8%Common at start; usually resolves within weeks
Fatigue / drowsiness
8%May improve; consider taking at night
Sweating
7%Often worse at night; usually improves with time
Weight gain
5-10% long-termMonitor weight; regular exercise helps mitigate
Tremor
5%Report if bothersome; dose adjustment may help
Serious Adverse Effects
- • Suicidal ideation (under-25, first weeks)
- • Serotonin syndrome
- • QT prolongation / cardiac arrhythmia
- • Discontinuation syndrome
- • Hyponatremia
Drug Interactions
Major Interactions (Avoid)
Moderate Interactions (Caution)
Food Interactions
When to Contact Your Doctor
This medication requires ongoing medical supervision. The following situations warrant a prompt conversation with your prescribing physician — do not wait for your next scheduled appointment.
Contact soon if you notice
- Suicidal ideation (under-25, first weeks)
- Serotonin syndrome
- QT prolongation / cardiac arrhythmia
- Discontinuation syndrome
- "Brain zaps" — electric shock sensations in the head
Also discuss if you want to
- Review whether this medication is still appropriate for you
- Consider dosage adjustments based on response
- Explore lifestyle or non-drug alternatives
- Understand stopping or tapering options
- Plan monitoring labs and follow-up
In the US, call 911 or go to the nearest emergency room for severe symptoms. Poison Control: 1-800-222-1222.
Special Populations
Safety classifications for specific groups — discuss with your provider before use.
PPHN risk; weigh against depression risks.
Low milk levels; discuss with provider.
Depression, anxiety, and mood instability during perimenopause are often hormone-driven, not a primary psychiatric condition. Lexapro is widely prescribed for what is actually estrogen and progesterone fluctuation. Hormone therapy may be more effective and more directly addresses the cause. Ask about a hormonal workup before starting an SSRI for symptoms that began near menopause.
FDA approved for adolescents. Black box warning.
Hyponatremia risk; start at 5mg; max 10mg in elderly.
FDA Adverse Event Reports
Patient-filed reports from the FDA FAERS database · refreshed daily
Community Reports
User-reported experiences — anonymous & anecdotal
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Metabolic & Lifestyle Alternatives
Non-Pharmacological Anxiety & Depression Treatments
CBT and exercise match escitalopram effectiveness in multiple trials
Important context: Evidence quality varies across these approaches. Some are well-studied with randomized controlled trial data; others are based on observational or smaller studies. These interventions are not guaranteed to replace medication for all patients. Discuss with your doctor whether any of these are appropriate for your clinical situation.
How It Compares
Escitalopram consistently ranks as the most efficacious and best-tolerated SSRI in independent network meta-analyses (including the 2018 Cipriani Lancet analysis of 522 trials).
Strengths
- Best tolerability of any SSRI in head-to-head studies
- Most selective SSRI — fewest off-target effects
- Effective for depression, GAD, social anxiety, panic, OCD
- Simple dosing (10mg or 20mg)
Weaknesses
- Sexual dysfunction still present (30–40%)
- QTc prolongation at higher doses (20mg) — check ECG in cardiac patients
- Not the cheapest (though generic available)
Clinically Preferred Alternatives
Global Prescribing & Pricing
US SSRI prescribing rates are approximately 3–4× higher than comparable European countries per capita
United States
$10–20 (generic)/mo
Top-10 prescribed drug; widely used for depression and anxiety
Any physician can prescribe; therapy not required before or during treatment
Varies by plan
United Kingdom
~$1–4/mo
Lower prescribing — therapy-first model per NICE
CBT or talking therapy required before SSRIs for mild-to-moderate cases; free IAPT access
Fully covered by NHS
Germany
~$9–22/mo
~6% of adults — psychotherapy co-subsidized
GKV pays for psychotherapy alongside medication; integrated treatment model is standard
Covered by GKV
Sweden
~$3–10/mo
~6% of adults — stepped care with exercise option
Structured exercise programs prescribable; stepped care ensures non-drug options first
Covered by Landsting
Japan
~$10–27/mo
Lower prescribing — cultural stigma + psychiatrist gatekeeping
Psychiatrist referral often required; shorter-duration prescriptions standard; strong social stigma
Covered by JHIS
Germany's GKV health insurance subsidizes psychotherapy wait times, meaning most patients access CBT before or alongside medication. A 2022 Lancet study confirmed medication + therapy produces better long-term outcomes than medication alone — yet only Germany and the UK make that the default path.
Clinical Trials & Funding
Understanding who funds research helps contextualize results. Industry-funded trials are not automatically invalid — they undergo the same FDA review — but declared conflicts and sponsor effects are worth knowing. All linked trials can be verified on ClinicalTrials.gov.
Funding Sources
Lundbeck funded most original trials. Publication bias prominent in antidepressant literature. FDA analysis showed smaller effects than published studies.
Declared Conflicts of Interest
Lundbeck funded extensive marketing campaigns. Key opinion leaders compensated for speaking and consulting.
Key Efficacy Results
Response 50-60%, remission 35%; slightly better tolerated than most SSRIs
Referenced Studies
Each study carries a Cochrane RoB-2 risk-of-bias badge — tap the badge for details.
Evidence & Transparency
Cochrane RoB-2 (Risk of Bias)
Badges reflect an editorial assessment using Cochrane's RoB-2 tool domains: randomization, intervention deviation, missing data, outcome measurement, and selective reporting. These are not certified Cochrane reviews. Learn more ↗
CMS Open Payments
Manufacturer payment disclosures are reported via the CMS Sunshine Act. Disclosure is legally required and does not imply bias or misconduct. Language uses "may," "suggests," or "appears" — never definitive clinical claims. CMS Open Payments ↗
Live Clinical Trials
Live from ClinicalTrials.gov · refreshed every 4 hours
Currently enrolling, active, and recently completed studies involving Escitalopram. Data is pulled directly from the U.S. National Library of Medicine.
Recent Research
Live from PubMed · peer-reviewed literature · refreshed every 4 hours
Most recently indexed clinical trials and systematic reviews mentioning Escitalopram in PubMed.
Source Documentation
Structured citations for referenced clinical trials
Each referenced trial is listed with its registry ID, funding source, and bias assessment. Use the copy button to generate a formatted citation.
| Trial | Registry ID | Cite |
|---|---|---|
| Escitalopram MDD (Forest) | NCT00668525 |
Bias ratings use Cochrane RoB-2 methodology. Editorial assessment — not a certified Cochrane review.
Our MethodologyMedical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Stopping This Medication Safely
Escitalopram has among the highest rates of SSRI discontinuation syndrome due to its short half-life. Symptoms begin within 24–48 hours of stopping and can be severely disabling.
What Published Research Shows About Stopping This Medication
This summarizes what published research documents — it is not personal medical advice. Any changes to your medication require discussion with your prescribing physician.
- ·Research shows discontinuation symptoms can begin within 24 hours of a missed dose — abrupt stopping is not documented as safe
- ·Published tapering approaches describe reducing by 2.5–5mg every 4–6 weeks minimum
- ·Liquid formulation is used by some patients for micro-tapering — this approach is supported by emerging evidence in sensitive individuals
- ·Research supports having CBT or therapy established before beginning dose reduction
- ·Clinical guidance suggests planning dose reduction during a lower-stress life period
Warning Symptoms — Contact Your Doctor If You Experience:
- "Brain zaps" — electric shock sensations in the head
- Extreme dizziness and nausea
- Severe mood swings
- Insomnia and vivid nightmares
- Anxiety worse than original symptoms
- Flu-like body aches and sweating
Never change or stop a medication without consulting your prescribing physician.
Questions for Your Doctor
Questions to Ask
- 1.Has the child's diet been evaluated? High-sugar and processed foods cause a blood sugar spike, then an insulin overcorrection, then a crash — and the body releases adrenaline to fix the crash. That adrenaline causes shakiness, anxiety, difficulty focusing, and restlessness — all of which can look exactly like ADHD. Has a dietary trial been done first?
- 2.Should we try therapy alongside this?
- 3.What side effects should I watch for?
- 4.How long until I notice a difference?
- 5.What is the plan for stopping if needed?
Lab Tests to Request
- ECG (QT interval, especially if cardiac history)
- Sodium (Na+)
- Thyroid function
- Vitamin D
- Fasting blood sugar — to check for reactive hypoglycemia
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Frequently Asked Questions About Lexapro®
- What is Lexapro® used for?
- Lexapro® (Escitalopram) is a SSRI manufactured by Generic. FDA-approved indications include: Major depressive disorder; Generalized anxiety disorder.
- What are the common side effects of Lexapro®?
- Common side effects of Lexapro® include: Nausea (15%); Sexual dysfunction (14-20%); Insomnia (14%); Diarrhea (12%); Dry mouth (9%).
- How much does Lexapro® cost?
- Lexapro® list price is approximately $120. With insurance it typically costs $10-30; without insurance approximately $20-50.
- Who funded the clinical trials for Lexapro®?
- Lundbeck funded most original trials. Publication bias prominent in antidepressant literature. FDA analysis showed smaller effects than published studies.
- How strong is the clinical evidence for Lexapro®?
- Key studies: Cipriani Lancet 2018 meta-analysis ranked it most effective and tolerated SSRI. Response 50-60%, remission 35%; slightly better tolerated than most SSRIs Potential conflicts of interest: Lundbeck funded extensive marketing campaigns. Key opinion leaders compensated for speaking and consulting..
- Are there non-drug alternatives to Lexapro®?
- CBT and exercise match escitalopram effectiveness in multiple trials See the Alternatives tab for full details.
Get notified when we update Lexapro®
We'll email you when new evidence, safety updates, or alternatives are added.
No spam. Unsubscribe anytime.